Search clinical trials for: Ropinirole XL (formerly CR)

Total 19 results

GlaxoSmithKline

Completed

Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164

Parkinson Disease

United States
GlaxoSmithKline

Completed

An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease

Parkinson's Disease | Parkinson Disease

United States, Spain, Poland, France, Belgium, Hungary, United Kingdom, Italy, Czech Republic
GlaxoSmithKline

Completed

Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)

Restless Legs Syndrome | Restless Legs Syndrome (RLS)

United States
Lupin Ltd.

Completed

Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions

Pharmacokinetic Study

India
GlaxoSmithKline

Terminated

A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.

Parkinson Disease

Japan
Lupin Ltd.

Completed

Two Way Cross Over BE Fasting Pilot Study of Ropinirole Hydrochloride CR 2mg Tablets

Pharmacokinetic Study

India
Lupin Ltd.

Completed

Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions

Pharmacokinetic Study

India
GlaxoSmithKline

Completed

Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome

Restless Legs Syndrome

Japan
St. Luke's-Roosevelt Hospital Center
GlaxoSmithKline

Completed

Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo

Sexual Dysfunction

United States
GlaxoSmithKline

Completed

A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda

Parkinson Disease

Belgium
GlaxoSmithKline

Completed

12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome ((CR-RLS))

Restless Legs Syndrome | Restless Legs Syndrome (RLS)

United States
Stanford University
GlaxoSmithKline; Duke University

Completed

Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression

Depressive Disorder, Major

United States
GlaxoSmithKline

Completed

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

Parkinson's Disease | Parkinson Disease | Dyskinesias

United States
Altria Client Services LLC
Cato Research

Completed

Characterization of Selected Aerosol Constituents Levels in the Exhaled Breath of Adult e-Vapor Users

Tobacco Use

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study

Depression | Suicidal Ideation

United States
M.D. Anderson Cancer Center
Novartis Pharmaceuticals; Celgene Corporation

Completed

PKC412 and 5-Azacytidine

Leukemia

United States
Marshall University

Recruiting

Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy

Pregnancy Related | Cardiac Output, Low | Systolic Hypertension | Cardiac Output, High | Diastolic Hypertension

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Terminated

Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression

Depression

United States
State University of New York - Downstate Medical...

Unknown

Coreg CR, Blood Vessel Stiffness and Blood Vessel Function

Hypertension | Diabetes Mellitus | Endothelial Function

United States

3

Subscribe